Danaher Diagnostics — Depreciation and amortization of intangible assets increased by 1.0% to $101.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.3%, from $95.00M to $101.00M. Over 3 years (FY 2021 to FY 2024), Diagnostics — Depreciation and amortization of intangible assets shows a downward trend with a -13.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate higher capital intensity or recent acquisition activity, while a decrease could suggest aging assets or a reduction in amortization schedules.
This metric represents the total non-cash expense recognized by the Diagnostics segment related to the systematic alloca...
Comparable to 'Depreciation and Amortization' reported by peer life sciences and medical technology companies, often used to calculate EBITDA.
dhr_segment_diagnostics_depreciation_and_amortization_of_intangible_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $153.50M | $153.50M | $153.50M | $147.50M | $147.50M | $147.50M | $147.50M | $144.25M | $144.25M | $144.25M | $144.25M | $97.00M | $100.00M | $95.00M | $102.00M | $100.00M | $100.00M | $101.00M |
| QoQ Change | — | +0.0% | +0.0% | -3.9% | +0.0% | +0.0% | +0.0% | -2.2% | +0.0% | +0.0% | +0.0% | -32.8% | +3.1% | -5.0% | +7.4% | -2.0% | +0.0% | +1.0% |
| YoY Change | — | — | — | — | -3.9% | -3.9% | -3.9% | -2.2% | -2.2% | -2.2% | -2.2% | -32.8% | -30.7% | -34.1% | -29.3% | +3.1% | +0.0% | +6.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.